Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Capital/Financing Update 2019

Feb 20, 2019

29745_rns_2019-02-20_f4b678e1-9c02-4db7-9feb-4a2993b97bb5.zip

Capital/Financing Update

Open in viewer

Opens in your device viewer

FWP 1 a2019finalllytermsheet.htm FWP html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd" Document created using Wdesk 1 Copyright 2019 Workiva Document

Free Writing Prospectus

Filed Pursuant to Rule 433

Registration Statement No. 333-229735

Dated February 20, 2019

Eli Lilly and Company

Pricing Term Sheet

3.375% Notes due 2029

3.875% Notes due 2039

3.950% Notes due 2049

4.150% Notes due 2059

Issuer: Eli Lilly and Company — 3.375% Notes due 2029 3.875% Notes due 2039 3.950% Notes due 2049 4.150% Notes due 2059
Principal Amount: $1,150,000,000 $850,000,000 $1,500,000,000 $1,000,000,000
Maturity Date: March 15, 2029 March 15, 2039 March 15, 2049 March 15, 2059
Coupon: 3.375% 3.875% 3.950% 4.150%
Public Offering Price: 99.846% of principal amount 99.900% of principal amount 99.439% of principal amount 99.378% of principal amount
Yield to Maturity: 3.393% 3.882% 3.982% 4.182%
Benchmark Treasury: 2.625% due February 15, 2029 3.375% due November 15, 2048 3.375% due November 15, 2048 3.375% due November 15, 2048
Spread to Benchmark Treasury: T+75 bps T+90 bps T+100 bps T+120 bps
Benchmark Treasury Price and Yield: 99-27 / 2.643% 107-22+ / 2.982% 107-22+ / 2.982% 107-22+ / 2.982%
Interest Payment Dates: March 15 and September 15, commencing September 15, 2019 March 15 and September 15, commencing September 15, 2019 March 15 and September 15, commencing September 15, 2019 March 15 and September 15, commencing September 15, 2019
Redemption Provisions:
Make-whole call: At any time at a discount rate of Treasury plus 12.5 basis points At any time at a discount rate of Treasury plus 15 basis points At any time at a discount rate of Treasury plus 15 basis points At any time at a discount rate of Treasury plus 20 basis points
Par call: On or after December 15, 2028 at 100% On or after September 15, 2038 at 100% On or after September 15, 2048 at 100% On or after September 15, 2058 at 100%
CUSIP / ISIN: 532457 BV9 / US532457BV93 532457 BS6 / US532457BS64 532457 BT4 / US532457BT48 532457 BU1 / US532457BU11
Trade Date: February 20, 2019
Settlement Date: T+2; February 22, 2019
Joint Book Running Managers: Deutsche Bank Securities Inc., Barclays Capital Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Credit Suisse Securities (USA) LLC
Co-Managers: Academy Securities, Inc., C.L. King & Associates, Inc., Samuel A. Ramirez & Company, Inc.

The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Deutsche Bank Securities Inc. at 800-503-4611, Barclays Capital Inc. at 1-888-603-5847, Merrill Lynch, Pierce, Fenner & Smith Incorporated at 1-800-294-1322 or Credit Suisse Securities (USA) LLC at 1-800-221-1037.

ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.